News | TCTAP 2022

Was 2021 a bad year for FFR-guided PCI?

William F. Fearon, MD says analysis of FUTURE, FLOWER-MI and FAME 3 trials show FFR-guided PCI still beneficial for select patients with multivessel CAD

May 19, 2022 3812 0 Read More

News | TCTAP 2022

‘CABG helps people live longer’

Cardiac surgeon S. Christopher Malaisrie, MD says CABG improves survival for MVD and LMCAD, despite recent guideline downgrades

May 13, 2022 6451 0 Read More

News | TCTAP 2022

Is CABG the best approach for multivessel, left main CAD?

Mario F.L. Gaudino, MD says PCI and CABG are complementary - not antagonistic – strategies for patients with MVD, LMCAD

May 13, 2022 4595 0 Read More

News | TCTAP 2022

‘Modern trials on SIHD revascularization show no mortality benefit with CABG over medical therapy’

Sripal Bangalore, MD explains 2021 American revasc guidelines sift out old mortality data, throw weight behind contemporary ones

May 12, 2022 11208 0 Read More

News | TCTAP 2022

Tailored de-escalation strategy in PCI and ACS: platelet function test and genetic test guidance

At TCTAP 2022, Dominick J. Angiolillo, MD outlines de-escalation strategies with PFT, genetic tests for PCI-ACS

May 04, 2022 4016 0 Read More